G764-0041 Screening compound: N-[2-(trifluoromethyl)phenyl]-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide

G764-0041 Screening compound: N-[2-(trifluoromethyl)phenyl]-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide
G764-0041 Screening compound: N-[2-(trifluoromethyl)phenyl]-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G764-0041
N-[2-(trifluoromethyl)phenyl]-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G764-0041

Molecular Formula

C23H21F3N4O (C23 H21 F3 N4 O)

Compound Name

N-[2-(trifluoromethyl)phenyl]-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide

IUPAC name

N-[2-(trifluoromethyl)phenyl]-5'H-spiro[piperidine-44'-pyrrolo[12-a]quinoxaline]-1-carboxamide

SMILES

O=C(Nc1c(C(F)(F)F)cccc1)N(CC1)CCC11Nc(cccc2)c2-n2c1ccc2

InChI

InChI=1S/C23H21F3N4O/c24-23(25,26)16-6-1-2-7-17(16)27-21(31)29-14-11-22(12-15-29)20-10-5-13-30(20)19-9-4-3-8-18(19)28-22/h1-10,13,28H,11-12,14-15H2,(H,27,31)

InChI Key

AWQBMZBXSBNTIG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15034013

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.44

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.086

Distribution Coefficient, logD

5.086

Water Solubility, LogSw

-5.03

Polar Surface Area

38.517

Acid Dissociation Constant (pKa)

13.79

Base Dissociation Constant (pKb)

7.80

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

G764-0041 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Proteases
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G764-0041 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G764-0041?
Check Price and Availability of G764-0041, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G764-0041 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G764-0041
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G764-0041
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G764-0041 available by request